TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18723699

Group type: EXPERIMENTAL
Intervention: Alder Hey Triage Pain Score (AHTPS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Wong-Baker Faces Pain Rating Scale (WBS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 75
Study: 15969319

Group type: EXPERIMENTAL
Intervention: Loprin (test product)
Number of subjects: 16
Study: 12638032

Group type: EXPERIMENTAL
Intervention: Phytosterol-enriched spread (2 x 10 g daily)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo spread
Number of subjects: 85
Study: 10576398

Group type: EXPERIMENTAL
Intervention: Conditioned group receiving an 8‐s 70‐db tone paired with a 500‐ms electric shock in a delay conditioning paradigm.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group receiving the CS and UCS on a truly random schedule.
Number of subjects: 0
Study: 7749448

Group type: EXPERIMENTAL
Intervention: Manual compression with a pressure dressing
Number of subjects: 503

Group type: COMPARATOR
Intervention: Mechanical compression with a pressure dressing
Number of subjects: 503

Group type: COMPARATOR
Intervention: Crossover from mechanical to manual compression
Number of subjects: 503
Study: 2102123

Group type: EXPERIMENTAL
Intervention: Extracranial-intracranial bypass surgery
Number of subjects: 1464

Group type: COMPARATOR
Intervention: Controlled clinical trial (medical treatment)
Number of subjects: 1464
Study: 380456

Group type: EXPERIMENTAL
Intervention: Monomycin with a diet with an excessive protein content (25% higher than the physiological norm)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control groups (60 children, 3 groups of 20 each) without excessive protein diet
Number of subjects: 80
Study: 31947884

Group type: EXPERIMENTAL
Intervention: Play-based intervention (physical activity, play, and nutritional advice)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Nutritional advice only (control group)
Number of subjects: 49
Study: 30641691

Group type: EXPERIMENTAL
Intervention: Glimepiride 2 mg twice daily + l-carnitine 1 g twice daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: Glimepiride 2 mg twice daily
Number of subjects: 58
Study: 28434269

Group type: EXPERIMENTAL
Intervention: Device with reminder features enabled
Number of subjects: 1306

Group type: COMPARATOR
Intervention: Device with reminder features disabled
Number of subjects: 1306

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1306
Study: 25487638

Group type: EXPERIMENTAL
Intervention: Achilles tendon taps
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dorsiflexion stretches
Number of subjects: 6
Study: 23274601

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI, 8°C)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (CONT, seated in normal ambient conditions)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 9
Study: 21866652

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Combination of Chinese medicine and chemotherapy
Number of subjects: 91
Study: 19519904

Group type: EXPERIMENTAL
Intervention: One-time educational intervention (40-minute session)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Teach-to-goal educational intervention (40-minute session + 20 minutes of additional education + periodic follow-up phone calls)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Control group (usual care after the initial education session)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Both groups (initial education session)
Number of subjects: 660
Study: 17145735

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 108
Study: 14971963

Group type: EXPERIMENTAL
Intervention: Treadmill walking program (3 times per week, low-endurance walking at 0% incline)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Treadmill walking program
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (nontreadmill, n = 12)
Number of subjects: 14
Study: 11699024

Group type: EXPERIMENTAL
Intervention: Transport Thermal Mattress (TTM)
Number of subjects: 191

Group type: COMPARATOR
Intervention: No Mattress
Number of subjects: 191
Study: 9029226

Group type: EXPERIMENTAL
Intervention: High intensity training (80% maximal O2 uptake)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Moderate intensity training (50% maximal O2 uptake)
Number of subjects: 26
Study: 7953034

Group type: EXPERIMENTAL
Intervention: Intensive aftercare by community psychiatric nurse (CPN) team with a case management approach (n = 52 contacts)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Generic care by community psychiatric nurse (CPN) team (n = 13 contacts)
Number of subjects: 82
Study: 3311432

Group type: EXPERIMENTAL
Intervention: Midazolam (12.5 mg) with ketamine (250 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Diazepam (20 mg) with ketamine (250 mg)
Number of subjects: 50
Study: 31645162

Group type: EXPERIMENTAL
Intervention: SGA
Number of subjects: 2315

Group type: COMPARATOR
Intervention: AGA
Number of subjects: 2315
Study: 29914924

Group type: EXPERIMENTAL
Intervention: Oral cephalexin 500 mg four times daily
Number of subjects: 206

Group type: COMPARATOR
Intervention: Intravenous cefazolin 2 g daily plus oral probenecid 1 g daily
Number of subjects: 206
Study: 26954311

Group type: EXPERIMENTAL
Intervention: Apremilast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Apremilast (30 mg twice weekly)
Number of subjects: 0
Study: 24992187

Group type: EXPERIMENTAL
Intervention: Cognitive training group
Number of subjects: 119

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 119
Study: 23740633

Group type: EXPERIMENTAL
Intervention: Exercise program (8 weeks duration, consisting of stretching, muscle strength training, balance training, and toe stretching)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 196
Study: 20209170

Group type: COMPARATOR
Intervention: Standard Transbond primer (Control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fluoride‐releasing primer (Reliance fluoride containing light cure bond)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Antimicrobial fluoride‐releasing self‐etching primer (Clearfil Protect Bond)
Number of subjects: 120
Study: 18414108

Group type: EXPERIMENTAL
Intervention: Travoprost ophthalmic solution 0.004% (BAK-free)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Travoprost ophthalmic solution 0.004% (with BAK)
Number of subjects: 109
Study: 16828939

Group type: EXPERIMENTAL
Intervention: Influenza vaccination (2004/2005 influenza vaccine)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 12811363

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (1200 mg/d)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11341181

Group type: EXPERIMENTAL
Intervention: Histoacryl (H)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Dermabond (D)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Histoacryl (H) and Dermabond (D)
Number of subjects: 157
Study: 8629722

Group type: EXPERIMENTAL
Intervention: Assured treatment design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 1596224

Group type: EXPERIMENTAL
Intervention: 1000 centistokes of silicone oil
Number of subjects: 101

Group type: COMPARATOR
Intervention: 20% sulfur hexafluoride gas and air
Number of subjects: 101
Study: 6397333

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 200 mg to 400 mg daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Piroxicam 20 mg to 40 mg daily
Number of subjects: 50
Study: 30442550

Group type: EXPERIMENTAL
Intervention: Small-sized particles (0.25-1mm)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Large-sized particles (1-2mm)
Number of subjects: 10
Study: 28452829

Group type: EXPERIMENTAL
Intervention: BTrackS Balance Test on days 1, 3, 8, and 15
Number of subjects: 20
Study: 26135853

Group type: EXPERIMENTAL
Intervention: Naltrexone (25 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 25428433

Group type: EXPERIMENTAL
Intervention: OPT program plus usual care
Number of subjects: 4730

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 4730

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 4730
Study: 22155448

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pentax AirwayScope
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Storz C‐MAC
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: McGrath Series5
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Glidescope Ranger
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope, Airtraq, Storz C‐MAC
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ambu Pentax AWS, Glidescope Ranger
Number of subjects: 23
Study: 19995412

Group type: EXPERIMENTAL
Intervention: Environmentally tailored intervention
Number of subjects: 1971

Group type: COMPARATOR
Intervention: Basic tailored intervention
Number of subjects: 1971
Study: 17446985

Group type: EXPERIMENTAL
Intervention: White noise during testing sessions
Number of subjects: 78
Study: 15162273

Group type: EXPERIMENTAL
Intervention: Phacoemulsification technique
Number of subjects: 94

Group type: COMPARATOR
Intervention: Extracapsular cataract extraction
Number of subjects: 94
Study: 11593107

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Irbesartan 150 mg once daily
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg b.i.d.
Number of subjects: 13
Study: 9704709

Group type: EXPERIMENTAL
Intervention: Filgrastim 5 microg/kg plus SCF (doses of 5, 10, 15, and 20 microg/kg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Filgrastim 5 microg/kg alone
Number of subjects: 48
Study: 7989631

Group type: EXPERIMENTAL
Intervention: Hypnosis before injection
Number of subjects: 29

Group type: COMPARATOR
Intervention: No hypnosis (control)
Number of subjects: 29
Study: 2722725

Group type: EXPERIMENTAL
Intervention: Cefmetazole (2 g single dose administered IV within 90 min of operation)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Cefoxitin (2 g single dose preoperative and two additional doses at 6 h intervals post-surgery)
Number of subjects: 195
Study: 30071525

Group type: EXPERIMENTAL
Intervention: Diet II - low fat diet
Number of subjects: 239

Group type: COMPARATOR
Intervention: Diet I - high fat diet
Number of subjects: 239
Study: 26501700

Group type: EXPERIMENTAL
Intervention: GLN-supplemented parenteral nutrition (GLN-PN)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard GLN-free parenteral nutrition (STD-PN)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: GLN-PN
Number of subjects: 150

Group type: COMPARATOR
Intervention: STD-PN
Number of subjects: 150
Study: 25657064

Group type: EXPERIMENTAL
Intervention: LCZ696
Number of subjects: 301

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 301
Study: 23689261

Group type: EXPERIMENTAL
Intervention: Rabeprazole 5 mg
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg
Number of subjects: 349

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Treatment-experienced infants
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Treatment-naïve infants
Number of subjects: 349
Study: 20862932

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at Renying (ST 9), Fengfu (GV 16), Baihui (GV 20)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Shenmai injection combined with 250 mL 5% Glucose injection
Number of subjects: 90
Study: 18795987

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 16262971

Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 0
Study: 12564351

Group type: EXPERIMENTAL
Intervention: 20-minute back massage
Number of subjects: 46
Study: 10370789

Group type: EXPERIMENTAL
Intervention: Platinum drug treatment
Number of subjects: 46
Study: 8683652

Group type: EXPERIMENTAL
Intervention: Maneuver A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maneuver B
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-treatment instructions
Number of subjects: 0
Study: 1761494

Group type: EXPERIMENTAL
Intervention: Cold water immersion (15 degrees C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole body exposure (15 degrees C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upper torso exposure (15 degrees C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower torso exposure (15 degrees C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control immersion (34 degrees C)
Number of subjects: 0
Study: 7052117

Group type: EXPERIMENTAL
Intervention: Routine regular antenatal cardiotocography (CTG)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Concealed CTG tracings
Number of subjects: 353

Group type: COMPARATOR
Intervention: Revealed CTG tracings
Number of subjects: 353
Study: 31155298

Group type: EXPERIMENTAL
Intervention: Regenerative endodontic procedures (REPs)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional root canal treatment (CRCT)
Number of subjects: 56
Study: 27311651

Group type: EXPERIMENTAL
Intervention: Personalized Web‐based decision support tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Educational pamphlet (control)
Number of subjects: 0
Study: 26025328

Group type: EXPERIMENTAL
Intervention: 480 mg choline/day
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 930 mg choline/day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no specified choline intake)
Number of subjects: 49
Study: 22826133

Group type: EXPERIMENTAL
Intervention: Trial 1 (AIH): eight 4 min episodes of hypoxia
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Trial 2 (ACH): continuous hypoxia for 32 min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Trial 3 (Control): euoxia throughout
Number of subjects: 12
Study: 18948611

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 10101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10101
Study: 15743150

Group type: EXPERIMENTAL
Intervention: Hormonal therapy with external-beam radiation (EBRT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormonal therapy with brachytherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole-pelvic EBRT and hormonal therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormonal therapy with brachytherapy without pelvic radiotherapy
Number of subjects: 0
Study: 12519868

Group type: EXPERIMENTAL
Intervention: Oxandrolone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 11228682

Group type: EXPERIMENTAL
Intervention: E-mail distributed evaluations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mailed evaluations
Number of subjects: 0
Study: 8780961

Group type: COMPARATOR
Intervention: Analog malingerers feigning deficits without task-specific instruction
Number of subjects: 3

Group type: COMPARATOR
Intervention: Analog malingerers feigning deficits with task-specific instruction
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Analog malingerers
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Self-report measures of postconcussive symptoms
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Clinical tests
Number of subjects: 3
Study: 1995258

Group type: EXPERIMENTAL
Intervention: Nifedipine (up to 20 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Verapamil (160 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6437814

Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (TNG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (38 patients treated conventionally)
Number of subjects: 39
Study: 31889177

Group type: EXPERIMENTAL
Intervention: Group A (rods and implants with DEAE-Dextran and Quil-A)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Group B (rods and implants with either DEAE-Dextran or Quil A)
Number of subjects: 12
Study: 30698654

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study: 28190578

Group type: EXPERIMENTAL
Intervention: Quadpill (irbesartan 37.5 mg, amlodipine 1.25 mg, hydrochlorothiazide 6.25 mg, atenolol 12.5 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 25403919

Group type: EXPERIMENTAL
Intervention: AG-PUFA (3 g/day for 8 weeks)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: EE-PUFA (3 g/day for 8 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 24954344

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine combined with intravenous patient-controlled analgesia (ITM-IVPCA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Patient-controlled thoracic epidural analgesia (PCTEA)
Number of subjects: 64
Study: 22882288

Group type: EXPERIMENTAL
Intervention: Aggressive parenteral nutrition (PN) (amino acids 3 g/kg per day and lipids 2 g/kg per day on first day of life)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conventional PN (amino acids 1.5 g/kg per day and lipids 1 g/kg per day on first day of life)
Number of subjects: 53
Study: 19543114

Group type: EXPERIMENTAL
Intervention: Concentrated formula (CF) 87 kcal/100 mL for 8 weeks
Number of subjects: 1998

Group type: COMPARATOR
Intervention: Standard formula (SF) 67 kcal/100 mL for 8 weeks
Number of subjects: 1998
Study: 17265483

Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg subcutaneously every other week)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo followed by Adalimumab (for 24 weeks)
Number of subjects: 151
Study: 15860855

Group type: EXPERIMENTAL
Intervention: Adjuvant anthracycline-based chemotherapy
Number of subjects: 937

Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 937
Study: 12576934

Group type: EXPERIMENTAL
Intervention: Oral doxifluridine 1,000 mg/m²/d plus leucovorin 30 mg/d on days 1 to 7 and 15 to 21 of each cycle (group A)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Intravenous 5‐fluorouracil 400 mg/m²/d plus leucovorin 20 mg/m²/d on days 1‐5 of each cycle (group B)
Number of subjects: 77
Study: 10220204

Group type: EXPERIMENTAL
Intervention: 1600 i.u. daily oral alpha-tocopherol for 8 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 9015560

Group type: EXPERIMENTAL
Intervention: Flavor conditioning (CS+ with facial expression of dislike)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Color conditioning (CS- with facial expression of dislike)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test drinks with local context cues (colors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Explicit beliefs in CS = Flavor groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Explicit beliefs in CS = Color groups
Number of subjects: 0
Study: 1340687

Group type: COMPARATOR
Intervention: 500 micrograms BIM (continuous s.c. infusion for 24 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 1500 micrograms/24h BIM (as 500 micrograms x 3 s.c. injections, 750 micrograms x 2 s.c. injections, and continuous s.c. infusion)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 30 mg IM of a long acting formulation of BIM
Number of subjects: 10
Study: 6426075

Group type: EXPERIMENTAL
Intervention: Azlocillin and gentamicin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Carbenicillin and gentamicin
Number of subjects: 20
Study: 31279613

Group type: EXPERIMENTAL
Intervention: Telephone-administered psycho-education with behavioral activation intervention (TBA)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Telephone-based psycho-education with general monitoring (TGM)
Number of subjects: 96
Study: 30343626

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy (FS) screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Model predictions for CRC incidence and mortality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screen-detected cancers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screen-detected adenomas
Number of subjects: 0
Study: 27035159

Group type: EXPERIMENTAL
Intervention: edivoxetine 12 mg + SSRI
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: edivoxetine 18 mg + SSRI
Number of subjects: 231

Group type: COMPARATOR
Intervention: placebo + SSRI
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: edivoxetine 12-18 mg + SSRI
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: edivoxetine 6 mg + SSRI
Number of subjects: 231
Study: 25301963

Group type: EXPERIMENTAL
Intervention: GDM group (n = 22)
Number of subjects: 52
Study: 22156967

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (5 sessions of 2 hours each focused on sexual risk-reduction information and exercises)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Standard HIV counseling and testing (baseline)
Number of subjects: 283
Study: 19889829

Group type: EXPERIMENTAL
Intervention: Dairy-supplemented diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Soy-supplemented diet
Number of subjects: 20
Study: 18028017

Group type: EXPERIMENTAL
Intervention: Anastrozole (5 years treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen (5 years treatment)
Number of subjects: 0
Study: 16187009

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg daily for 4 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Atenolol 50 mg daily for 4 weeks
Number of subjects: 35
Study: 12097809

Group type: EXPERIMENTAL
Intervention: 8 million IU IFN‐beta‐1b
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (NaCl)
Number of subjects: 8
Study: 9933696

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA) with 2% lidocaine (15-20 ml), midazolam (5-10 mg), and fentanyl (<250 microg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 64